IL-1β induces serine protease inhibitor 3 (SPI-3) gene expression in rat pancreatic β-cells. Detection by differential display of messenger RNA

Cytokine

Volumn 11, Issue 11, 1999, Pages 856-862

  Chen, Meng Chi ^a   Schuit, Frans ^a   Pipeleers, Daniel G ^a   Eizirik, Décio L ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

Acute phase protein; DDRT PCR; Interleukin 1; Serine protease inhibitor 3; cells

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SERINE PROTEINASE INHIBITOR; ACUTE PHASE PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; NOS2 PROTEIN, RAT; PROTEIN SYNTHESIS INHIBITOR; SERPINA3N PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE ISOLATION; GENETIC TRANSCRIPTION; INFLAMMATION; INSULINOMA; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; METABOLISM; PANCREAS ISLET; WISTAR RAT;

ANIMALIA;

ACUTE-PHASE PROTEINS; ANIMALS; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION; INTERFERON TYPE II; INTERLEUKIN-1; ISLETS OF LANGERHANS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; SERPINS; TRANSCRIPTION, GENETIC;

EID: 0032585927     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0525     Document Type: Article

References (30)

1. Bach JF. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J Autoimmun. 8:1995;439-463.
2. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1996;1005-1029.
3. Eizirik DL, Pavlovic D. Is there a role for nitric oxide in β-cell dysfunction and damage in IDDM? Diabetes Metab Rev. 13:1997;293-308.
4. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol. 55:1998;1139-1149.
5. Eizirik DL, Flodström M, Karlsen AE, Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 39:1996;875-890.
6. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 274:1992;787-789.
7. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 21:1993;3269-3275.
8. Pages G, Rouayrenc JF, Le Cam G, Mariller M, Le Cam A. Molecular characterization of three rat liver serine-protease inhibitors affected by inflammation and hypophysectomy. Eur J Biochem. 190:1990;385-391.
9. Tsuda M, Kitagawa K, Imaizumi K, Wanaka A, Tohyama M, Takagi T,. Induction of SPI-3 mRNA, encoding a serine protease inhibitor, in gerbil hippocampus after transient forebrain ischemia. Mol Brain Res. 35:1996;314-318.
10. Welsh N, Bendtzen K, Sandler S. Influence of protease on inhibitory and stimulatory effects of interleukin 1β on β-cell function. Diabetes. 40:1991;290-294.
11. Eizirik DL, Bendtzen K, Sandler S. Short exposure of rat pancreatic islets to interleukin-1β induces a sustained but reversible impairment in β-cell function: influence of protease activation, gene transcription, and protein synthesis. Endocrinology. 128:1991;1611-1616.
12. Bauer D, Müller K, Reich J, Riedel H, Ahrenkiel V, Warthoe P, Strauss M. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res. 21:1993;4272-4280.
13. Ling Z, Chen MC, Smismans A, Pavlovic D, Schuit F, Eizirik DL, Pipeleers DG. Intercellular differences in interleukin-1β-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic β-cells. Endocrinology. 139:1998;1540-1545.
14. Darville MI, Eizirik DL. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia. 41:1998;1101-1108.
15. Rafaellof R, Qin XF, Barlow SW, Rosenberg L, Vinik AL. Identification of differentially displayed genes induced in pancreatic islet neogenesis. FEBS Lett. 378:1996;219-223.
16. Yaswen P, Smoll A, Peehl DM, Trask DK, Sager R, Stampfer M. Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc Natl Acad Sci U S A. 87:1990;2319-2323.
17. Lee SW, Tomasetto C, Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A. 88:1991;2825-2829.
18. Ling Z, In't Veld PA, Pipeleers DG. Interaction of interleukin-1 with islet β-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes. 42:1993;56-65.
19. Eizirik DL, Björklund A, Welsh N. Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett. 317:1993;62-66.
20. Flodström M, Niemann A, Bedoya FJ, Morris SM Jr, Eizirik DL. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic β-cells: induction of argininosuccinate synthetase by cytokines. Endocrinology. 136:1995;3200-3206.
21. Rossi V, Rouayrenc JF, Paquereau L, Vilarem MJ, Le Cam A. Analysis of proteins binding to the proximal promoter region of two rat serine protease inhibitor genes. Nucleic Acids Res. 20:1992;1061-1068.
22. Kordula T, Travis J. Activation of the rat serine proteinase inhibitor 3 gene by interferon γ via the interleukin 6-responsive element. Biochem J. 309:1995;63-67.
23. Kordula T, Travis J. The role of Stat and C/EBP transcription factors in the synergistic activation of rat serine protease inhibitor-3 gene by interleukin-6 and dexamethasone. Biochem J. 313:1996;1019-1027.
24. Bedoya FJ, Flodström M, Eizirik DL. Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Commun. 210:1995;816-822.
25. Pipeleers DG, In't Veld PA, Van De Winkel M, Maes E, Schuit FC, Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology. 117:1985;806-816.
26. Ling Z, Hannaert JC, Pipeleers DG. Effect of nutrients, hormones and serum on survival of rat islet B cell. Endocrinology. 117:1994;834-840.
27. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Niemann A, Geller DA, Pipelleers D, Bendtzen K, Hellerström C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest. 93:1994;1968-1974.
28. Niemann A, Björklund A, Eizirik DL. Studies on the molecular regulation of the inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Mol Cell Endocrinol. 106:1994;151-155.
29. Eizirik DL, Björklund A, Cagliero E. Genotoxic agents increase expression of growth arrest and DNA damage-inducible genes gadd 153 and gadd 45 in rat pancreatic islets. Diabetes. 42:1993;738-745.
30. Wallestein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.